Increased investment in biotech, robotics and videoconferencing result from the COVID-19 outbreak. Plus, no more handshakes!
Silicon Dragon Connects Innovators and Investors In the World's Leading Tech Hubs
Good news! We have received word that Rebecca Fannin’s new book, Tech Titans of China, has won a Silver Medal for best international business book of 2020, presented by Axiom Business Book Awards. The...
Will disruption again lead to new innovation and investment opportunities for VCs and startups that once freely traveled the US-China highway?
Issues over national security threats and competition with China for future technology leadership are stopping the flow of China investment in US tech companies. Cross-border U.S.-China collaboration that has long fueled next-generation innovations is being stifled.
First of China’s podcasting-type players goes public on Nasdaq and raises $45 million, with investors Morningside, Xiaomi, Orchid Asia, TPG and Matrix in tow.
The U.S. is sliding as the uncontested global leader in R&D. Its share of total R&D spending globally slipped from 37% to 25% since 2010, the National Science Board finds. China gained to 23%.